IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.
复制标题
DOI:
10.1086/657146
复制
发表时间:
2010-12-01
期刊:
影响因子:
--
通讯作者:
Thio CL
中科院分区:
文献类型:
--
作者:
Martin MP;Qi Y;Goedert JJ;Hussain SK;Kirk GD;Hoots WK;Buchbinder S;Carrington M;Thio CL
An IL28B haplotype strongly determines the outcome of natural and interferon-α treated HCV infection. To assess if the polymorphism marking the haplotype (rs12979860) also affects other interferon-α responsive chronic viral illnesses, namely hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV), we genotyped 226 individuals with HBV persistence, 384 with HBV recovery, and 2548 with or at high-risk for HIV infection. The C/C genotype of rs12979860 was not associated with HBV recovery (OR 0.99), resistance to HIV infection (0.97), or HIV disease progression (P>0.05). This IL28B SNP affects the immune response to HCV but not to HBV or HIV.
登录
查看更多内容
影响因子:
3.7
作者:
Lapenta, C;Santini, SM;Belardelli, F
通讯作者:
Belardelli, F
影响因子:
4.5
作者:
Fellay J;Ge D;Shianna KV;Colombo S;Ledergerber B;Cirulli ET;Urban TJ;Zhang K;Gumbs CE;Smith JP;Castagna A;Cozzi-Lepri A;De Luca A;Easterbrook P;Günthard HF;Mallal S;Mussini C;Dalmau J;Martinez-Picado J;Miro JM;Obel N;Wolinsky SM;Martinson JJ;Detels R;Margolick JB;Jacobson LP;Descombes P;Antonarakis SE;Beckmann JS;O'Brien SJ;Letvin NL;McMichael AJ;Haynes BF;Carrington M;Feng S;Telenti A;Goldstein DB;NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
通讯作者:
NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
影响因子:
5.4
作者:
Hou, Wei;Wang, Xu;Ho, Wen-Zhe
通讯作者:
Ho, Wen-Zhe
影响因子:
5.4
作者:
Thio, Chloe L.;Astemborski, Jacquie;Carrington, Mary
通讯作者:
Carrington, Mary
影响因子:
5
作者:
Hong, Seung-Ho;Cho, Okki;Park, Sun
通讯作者:
Park, Sun